- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06308289
Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique in COPD
Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique on Cardiorespiratory Fitness, Posture and Quality of Life in Chronic Obstructive Pulmonary Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Imran Amjad, Phd
- Phone Number: 03324390125
- Email: imran.amjad@riphah.edu.pk
Study Locations
-
-
Punjab
-
Gujranwala, Punjab, Pakistan, 52200
- Recruiting
- Social Security Hospital
-
Contact:
- Akhtar Hunjra, Phd
- Phone Number: 03041049249
- Email: ms.sshgw@pessi.punjab.gov.pk
-
Sub-Investigator:
- Komal Munir, DPT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 40-75 years diagnosed with stable COPD (according to GOLD guidelines).
- Patients of both genders
- FEV1: FVC ranging from 68 - 69%.
- Predicted FEV1 of less than 70%.
- Willingness to participate
Exclusion Criteria:
- Acute Exacerbation of COPD
- Participants with severe comorbidities, such as unstable cardiovascular diseases (e.g., recent myocardial infarction, uncontrolled hypertension)
- Participants diagnosed with respiratory conditions other than COPD (such as asthma, interstitial lung disease)
- Individuals who have undergone major thoracic or abdominal surgery within the past three months
- Individuals with severe mental health conditions (such as uncontrolled psychosis or severe depression)
- Pregnant or lactating individuals.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group A
GPRM and ACBT
|
Focusing on postural correction and movement patterns
Emphasizing breathing control, thoracic expansion, and mucus clearance techniques
|
Active Comparator: Group B
Standard Care for COPD (ACBT)
|
Emphasizing breathing control, thoracic expansion, and mucus clearance techniques
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SF- 36 Questionnaire
Time Frame: 12 Weeks
|
The 36-Item Short Form Survey (SF-36) is an outcome measure instrument that is often used, well-researched, self-reported measure of health. It stems from a study called the Medical Outcomes Study for the objective measure of the quality of life. It comprises 36 questions that cover eight domains of health:
|
12 Weeks
|
FEV1/FVC ratio
Time Frame: 12 Weeks
|
The individual inhales maximally and then exhales forcefully into a spirometer, measuring lung volume and airflow.
The procedure may be repeated multiple times to ensure accurate and consistent results.
|
12 Weeks
|
6-minute walk test
Time Frame: 12 Weeks
|
The Six-Minute Walk Test (6MWT) assesses exercise capacity. Participants are briefed and baseline vital signs are recorded. The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity. |
12 Weeks
|
Photogrammetry
Time Frame: 12 Weeks
|
Photogrammetry is a research tool used in COPD studies to assess physical changes.
It involves capturing and analyzing images of patients to measure anatomical features and body movement.
|
12 Weeks
|
Forced expiratory volume (FEV1)
Time Frame: 12 Weeks
|
The individual inhales maximally and then exhales forcefully into a spirometer, measuring lung volume and airflow.
The procedure may be repeated multiple times to ensure accurate and consistent results.
|
12 Weeks
|
Forced vital capacity (FVC)
Time Frame: 12 Weeks
|
The individual inhales maximally and then exhales forcefully into a spirometer, measuring lung volume and airflow.
The procedure may be repeated multiple times to ensure accurate and consistent results.
|
12 Weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Muhammad Faizan Hamid, Ms-CPPT, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/RCR&AHS/23/0361
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Global Posture Re-education
-
University of LahoreRecruitingCervical RadiculopathyPakistan
-
St. Justine's HospitalShriners Hospitals for Children; Laval University; Université de Montréal; CHU...RecruitingAdolescent Idiopathic ScoliosisCanada
-
Horus UniversityCairo UniversityRecruiting
-
University of BolognaCompleted
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompletedNeck Pain | Breast Feeding | Disability PhysicalPakistan
-
Universidad Francisco de VitoriaCompletedStress, PsychologicalSpain
-
Keimyung University Dongsan Medical CenterCompletedBowel PreparationKorea, Republic of